Dilaum Pharma Private Limited - Company Profile

It is a business services private limited company based in Pune, Maharashtra, India, established in 2017.
2017 Pune, Maharashtra, India Active
Last Updated:
Access Report
About Dilaum Pharma Private Limited

Dilaum Pharma Private Limited, a active private limited company, was established on 21 February 2017 in Pune, Maharashtra, India. Engaging in other services within the business services sector, it holds CIN: U74999PN2017PTC169026. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Ashwini Ashok Marathe (Director), Hardeep Bhalla (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shop No -6, Surbhi Complex, M.H.B.,Yerwada, Pune, Maharashtra, 411006.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999PN2017PTC169026

  • Registration Number

    169026

  • Incorporation Date

    21 February 2017

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 8 Days
  • Last Filing with ROC 31 Mar 2025
Company report

Dilaum Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dilaum Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Dilaum Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Ashwini Ashok Marathe Director 21 Feb 2017 Current
Hardeep Bhalla Director 21 Feb 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dilaum Pharma.

Dilaum Pharma Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Dilaum Pharma revenue growth over time
Dilaum Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dilaum Pharma?

Unlock access to Dilaum Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dilaum Pharma?

Unlock and access historical data on people associated with Dilaum Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dilaum Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dilaum Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dilaum Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Dilaum Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Dilaum Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was completed.

  • Director Appointment

    Ashwini Ashok Marathe was appointed as a Director was appointed as a Director on 21 Feb 2017 & has been associated with this company since 9 years 8 days . was recorded as a recent event.

  • Director Appointment

    Progress on Hardeep Bhalla was appointed as a Director was appointed as a Director on 21 Feb 2017 & has been associated with this company since 9 years 8 days . was documented.

  • Company Incorporation

    The activity Dilaum Pharma Private Limited was registered on 21 Feb 2017 with Roc Pune & aged 9 years 8 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dilaum Pharma Private Limited?

The CIN of Dilaum Pharma Private Limited is U74999PN2017PTC169026.

Where is Dilaum Pharma Private Limited headquartered?

Dilaum Pharma Private Limited is headquartered at Shop No -6, Surbhi Complex, M.H.B.,Yerwada, Pune, Maharashtra, 411006.

When was Dilaum Pharma Private Limited incorporated?

Dilaum Pharma Private Limited was incorporated on 21 February 2017.

Who are the current directors of Dilaum Pharma Private Limited?

The current directors of Dilaum Pharma Private Limited are

What is the primary industry of Dilaum Pharma Private Limited?

The primary industry of Dilaum Pharma Private Limited is Business Services.

Is Dilaum Pharma Private Limited a listed company?

Dilaum Pharma Private Limited is unlisted.

What is the capital structure of Dilaum Pharma Private Limited?

The authorized capital of Dilaum Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Dilaum Pharma Private Limited?

The compliance status of Dilaum Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available